Rodrigo Paredes De La Fuente

Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumab

Case report · BMJ Case Reports · 2023 · First of 3 authors · 2 citations

Evolving Trends in Latin American Participation in Global Oncology Clinical Trials: A Decade of Phase III Activity (2013-2022)

JCO Global Oncology · 2026 · First of 9 authors · 1 citations